Stockreport

Merck (MRK) Price Target Lifted at Morgan Stanley as Biopharma Outlook Improves [Yahoo! Finance]

Morgan Stanley  (MS) 
Last morgan stanley earnings: 4/16 07:15 am Check Earnings Report
US:NYSE Investor Relations: morganstanley.com/about-us-ir
PDF On December 12, Morgan Stanley lifted its price target on Merck & Co., Inc. (NYSE:MRK) to $102 from $100. The firm kept an Equal Weight rating on the stock. In its 2026 [Read more]